Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Med Virol ; 94(4): 1336-1349, 2022 04.
Artículo en Inglés | MEDLINE | ID: mdl-34845731

RESUMEN

The entire world has been suffering from the coronavirus disease 2019 (COVID-19) pandemic since March 11, 2020. More than a year later, the COVID-19 vaccination brought hope to control this viral pandemic. Here, we review the unknowns of the COVID-19 vaccination, such as its longevity, asymptomatic spread, long-term side effects, and its efficacy on immunocompromised patients. In addition, we discuss challenges associated with the COVID-19 vaccination, such as the global access and distribution of vaccine doses, adherence to hygiene guidelines after vaccination, the emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, and vaccine resistance. Despite all these challenges and the fact that the end of the COVID-19 pandemic is still unclear, vaccines have brought great hope for the world, with several reports indicating a significant decline in the risk of COVID19-related infection and hospitalizations.


Asunto(s)
COVID-19/prevención & control , SARS-CoV-2/inmunología , Vacunación , COVID-19/epidemiología , COVID-19/inmunología , COVID-19/virología , Vacunas contra la COVID-19/administración & dosificación , Vacunas contra la COVID-19/efectos adversos , Vacunas contra la COVID-19/inmunología , Vacunas contra la COVID-19/provisión & distribución , Salud Global , Humanos , Huésped Inmunocomprometido , Mutación , SARS-CoV-2/genética , Vacunación/efectos adversos , Vacunación/psicología , Vacilación a la Vacunación , Eficacia de las Vacunas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA